Bayer-Backed Boundless Bio Falls 9% After $100 Million IPO
Shares of Boundless Bio Inc., a cancer therapeutics maker that counts Bayer AG among its largest investors, fell nearly 11% after raising $100 million in a US initial public offering.
Shares of Boundless Bio Inc., a cancer therapeutics maker that counts Bayer AG among its largest investors, fell nearly 11% after raising $100 million in a US initial public offering.
A look at what investors will be watching in the upcoming week.
Blackwells Capital LLC asked a Delaware judge to force Walt Disney Co. to hand over records about its relationship with activist investor ValueAct Capital Management and the role it played in a fight over the makeup of the entertainment giant’s board of directors.
Blackstone Inc. sold 48 warehouses in Southern California to Rexford Industrial Realty Inc. for $1 billion.
The European Central Bank can’t ignore the economic risks of keeping interest rates high for too long and should begin cutting at one of its next two meetings, according to Governing Council member Francois Villeroy de Galhau.
{{ video.ContentPackages[0].ScheduleStartDateTime | fromNow }}
{{ currentStream.Desc }}